Abstract:Dihydronaphthyridine calcium antagonists are structurally related to the well known dihydropyridines and act in a similar manner. In order to establish the vascular selectivity of these compounds contractile force was evaluated in porcine isolated ventricular trabeculae and right coronary arteries. The dihydropyridine derivatives nisoldipine and nitrendipine as well as the structurally different compounds gallopamil and flunarizine were included for comparison purpose. All compounds studied exhibited dose-dependent negative inotropic and vasodilator activities. The negative inotropic potency of all dihydronaphthyridines, especially of the highly lipophilic bulky ester-variated derivatives (Goe 5584-A, Goe 5806-A) was comparable to that of flunarizine but was considerably less pronounced than that of nisoldipine, nitrendipine or gallopamil. By contrast, half-maximal vasodilator responses of the dihydronaphthyridines studied in coronary arteries being in the nanomolar concentration range were comparable to the dihydropyridines nisoldipine and nitrendipine, whereas the activity of gallopamil and flunarizine was less marked. On the other side the dihydronaphthyridines, especially the more hydrophilic 3-ethylester-4-(2-cyanophenyl) derivative Goe 5606, exerted an obvious biphasic concentration-response behaviour in coronary arteries leading to a high affinity relaxant process in subnanomolar concentrations, whereas the low affinity response could be observed at rather high concentrations (mostly greater than 1 microM). Mainly due to their relative uneffectiveness in cardiac muscle, vascular selectivity of the dihydronaphthyridines was considerably higher than that of the structurally related dihydropyridines nisoldipine resp. nitrendipine increasing in the following order: nitrendipine less than nisoldipine less than Goe 5606 less than Goe 5438 less than Goe 5584-A less than Goe 5806-A. By contrast, gallopamil exerted a slight cardiac preference, whereas the vascular selectivity of flunarizine was also pronounced.(ABSTRACT TRUNCATED AT 250 WORDS)

Characterization and bioactivity of novel calcium antagonists - N-methoxy-benzyl haloperidol quaternary ammonium salt

Comparative Qsar Study On A Novel Class Of N-Type Calcium Channel Blocks

Studies on calcium antagonist activities of 2-ethyl-3-carbmethoxy-4-aryl- 5-oxo-6,6-dimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives

Study on the synthesis,biological activity and QSAR of halophenoxylalkylamines as α1-AR antagonist

Synthesis and blocking activities of a new class of α₁-adrenoceptor antagonists.

Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle

Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Pyrimidine Derivatives as Potential Calcium Channel Blockers

Studies on Calcium Modulatory Activities of 2,6,6-Trimethyl-3-acetyl-4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline Derivatives

Ortho versus Meta Chlorophenyl-2,3-Benzodiazepine Analogues: Synthesis, Molecular Modeling, and Biological Activity as AMPAR Antagonists

L-type calcium channel antagonism - Translation from in vitro to in vivo

Discovery of Novel 3-Benzylquinazolin-4(3 H )-Ones As Potent Vasodilative Agents

The Experimental Study of Decrease Blood Pressure with MN9202

Molecular Simulations Study of Novel 1,4-Dihydropyridines Derivatives with A High Selectivity for Cav3.1 Calcium Channel

Synthesis and Biological Evaluation of XB-1 Analogues As Novel Histamine H3 Receptor Antagonists and Neuroprotective Agents

Studies On Synthesis And Biological Activity Of Pyridazinone Derivatives As Alpha(1)-Adrenoceptor Antagonist

Design, Synthesis, and Biological Evaluation of Benzofuran Derivatives As ET Receptor Antagonists

Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca 2+ channel modulator, in rat ventricular myocytes

Synthesis, Crystal Structure, Biological Evaluation, and Molecular Docking Studies of Quinoline-Arylpiperazine Derivative As Potent Α1a-Adrenoceptor Antagonist

Design, Synthesis, and Bioactivity of Pyrazole Acid Derivatives As Endothelin Receptor Antagonists

Studies on potassium channel openers ( I ) - Synthesis and cardiovascular activity of substituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2h-1-benzopyran-3-ols

Synthesis and Biological Activity of 2-Alkylbenzimidazoles Bearing a N-phenylpyrrole Moiety As Novel Angiotensin II AT1 Receptor Antagonists